Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-08-07

FDA Approved: REPAGLINIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

Supplemental approval for REPAGLINIDE filed by Macleods Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Repaglinide (Repaglinide)

Snippet

SUPPL AP for REPAGLINIDE (REPAGLINIDE)